Spontaneous hemarthrosis of the knee associated with clopidogrel and aspirin treatment

Related Experiment Video

Updated: Sep 27, 2026

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
14:38

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

Published on: January 4, 2019

J Gille1, J Bernotat, S Böhm

  • 1Department of Orthopaedics, University Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. justus_gille@usa.net

Zeitschrift Fur Rheumatologie
|March 8, 2003
PubMed

Insights

A 76-year-old man experienced spontaneous knee bleeding after taking clopidogrel-aspirin. This case highlights a rare complication of antiplatelet therapy, emphasizing prompt diagnosis and joint aspiration.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Clopidogrel, an ADP receptor antagonist, combined with aspirin is frequently prescribed for patients with atherosclerotic vascular disease to prevent ischemic events.
  • Antiplatelet therapy plays a crucial role in managing cardiovascular conditions, but potential bleeding complications require careful consideration.

Observation:

  • A case report details a 76-year-old male who developed spontaneous hemarthrosis (bleeding into a joint) in his right knee.
  • This event occurred subsequent to initiating treatment with clopidogrel and aspirin.

Findings:

  • The patient's spontaneous hemarthrosis following clopidogrel-aspirin therapy is the first such case documented in medical literature.
  • Prompt joint aspiration and cessation of the antiplatelet regimen are crucial for managing this complication.

Implications:

  • Spontaneous hemarthrosis should be considered a potential adverse effect of clopidogrel-aspirin therapy.
  • Early clinical evaluation for intraarticular effusion and prompt intervention can prevent further joint damage in patients on this medication.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...